In-house roundup: Simulations should be patentable; procedure rules may restrict appeals; trade secrets after Alice; Medicines Patent Pool interview

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house roundup: Simulations should be patentable; procedure rules may restrict appeals; trade secrets after Alice; Medicines Patent Pool interview

Drugs

Managing IP rounds up the latest news and analysis from patent-focused businesses



Money

Making simulations non-patentable ‘big step back for European industry’

The EPO Enlarged Board of Appeal’s decision in G1/19 is coming, and in-house counsel say it is important for their businesses and European innovation that computer-implemented simulations be patent eligible. Read More... 

New EPO procedural rules may restrict appeals but guidelines are ‘slight recipe change’

With the new examination guidelines and procedure rules coming into force, businesses reveal their views on changes to the ‘hope to succeed’ criteria and the earlier-communicated streamlining of the appeals process. Read more... 

Alice five years on: trade secrets are still popular alternative to patents

Businesses say they have increasingly turned to trade secrets since the 2014 SCOTUS decision because of the sustained ambiguity around Section 101; but add that there are challenges along that path too. Read more... 

Medicines Patent Pool model increases access to medicine with solid business case

In an exclusive interview with executive director Charles Gore, Patent Strategy learns how the MPP model increases access to HIV medicine while allowing innovators to benefit financially. Read more... 





more from across site and SHARED ros bottom lb

More from across our site

The insensitive reaction to a UK politician crying on TV proves we have a long way to go before we can say we are tackling workplace wellbeing
Adrian Percer says he was impressed by the firm’s work on billion-dollar cases as well as its culture
In our latest interview with women IP leaders, Catherine Bonner at Murgitroyd discusses technology, training, and teaching
Developments included an update in the VAR dispute between Ballinno and UEFA, the latest CMS updates, and a swathe of market moves
The LMG Life Sciences Americas Awards is thrilled to present the 2025 shortlist
A new order has brought the total security awarded to a Canadian tech company to $45 million, the highest-ever by an Indian court in an IP case
Andrew Blattman reflects on how IP practices have changed and shares his hopes for increased AI use and better performance on the stock market
The firm said major IP developments included advising on a ‘landmark’ deal involving green hydrogen production, as well as two major acquisitions
The appointments follow other recent moves in the European market as firms look to bolster their UPC offerings
Deborah Kirk discusses why IP and technology have become central pillars in transactions and explains why clients need practically minded lawyers
Gift this article